Legato Merger Corp. III (LEGT) Prices $175M IPO
by Marlena Haddad on 2024-02-05 at 5:11pm

Legato Merger Corp. III (NYSE: LEGT) announced the pricing of its $175 million IPO this evening. Its units are expected to begin trading on the NYSE American under the symbol “LEGT U” on Tuesday, February 6, 2024. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “LEGT” and “LEGT WS”, respectively.

Legato III intends to focus on target businesses in the infrastructure, engineering and construction, industrial and renewables industries.

The Company’s management team is comprised of Gregory Monahan, Chief Executive Officer and Director, Eric S. Rosenfeld, Chief SPAC Officer, Adam Jaffe, Chief Financial Officer, Secretary and Director, Brian Pratt, Director and Non-Executive Chairman of the Board, David D. Sgro, Director and Non-Executive Vice Chairman of the Board, and Adam Semler and John Ing, each a Director of the Company.

Total SPAC deal count for 2024 year-to-date is now 2. This offering is expected to close on Wednesday, February 7, 2024.


BTIG, LLC is acting as the sole book-running manager for the offering, with Craig-Hallum Capital Group LLC as co-manager.  Graubard Miller is serving as Issuer’s Counsel with Loeb & Loeb LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Equiniti Trust Company, LLC is acting as trustee.

Recent Posts
by Nicholas Alan Clayton on 2024-07-23 at 4:33pm

Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...

by Nicholas Alan Clayton on 2024-07-23 at 1:00pm

Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...

by Nicholas Alan Clayton on 2024-07-23 at 8:38am

At the SPAC of Dawn A new ripple is expected to come to the market today in the form of Ethereum spot ETFs after the SEC gave final approval to several yesterday. BlackRock, Fidelity, Bitwise, Franklin, and VanEck all received approval for their new funds and all but BlackRock plan to waive fees until they...

by Nicholas Alan Clayton on 2024-07-22 at 12:22pm

Maquia Capital (NASDAQ:MAQC) has entered into a definitive agreement to combine with AI infrastructure firm Velocium at a valuation of $445 million. Miami-based Velocium is developing data center processors designed to be particularly efficient for use by AI applications and Web 3.0. The combined company is expected to trade on the Nasdaq under the symbol...

by Nicholas Alan Clayton on 2024-07-22 at 8:24am

At the SPAC of Dawn The third week of July brings just three votes and only ARYA IV‘s (NASDAQ:ARYD) is to complete a transaction, but plenty more is turning in SPACland. For one, this week’s anticipated IPO for M3-Brigade V (NASDAQ:MBAV) now looks notably different with 1/2 warrants in its units and its trust overfunded...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved